Published in Pharma Investments, Ventures and Law Weekly, February 13th, 2011
The foremost obstacle is that the most promising preventive strategies are being tested in patients firmly in the grip of Alzheimer's disease - the ones least likely to be helped.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly